8 results
Stroke and bleeding risk stratification with the CHADS2-VASc and HAS-BLED schemas

#Diagnosis #Hematology #CHADS2 #CHADS2VASc #HASBLED #Comparison
Stroke and bleeding ... #Hematology #CHADS2 ... HASBLED #Comparison #Score ... Bleed #Anticoagulation ... #AFib
HAS-BLED Score: Estimates risk of major bleeding for patients on anticoagulation to assess risk-benefit in atrial
HAS-BLED Score: ... major bleeding ... #Diagnosis #HASBLED ... #Score #Risk #Bleed ... #AFib
Bleeding risk calculators - HAS-BLED (atrial fibrillation) and IMPROVE (VTE prophylaxis for inpatients)
Important notes:
 • No
Bleeding risk calculators ... #Risk #Scores # ... Calculators #Anticoagulation ... #Factors #Hematology ... #Diagnosis
CHA2DS2VASc vs HAS-BLED scores for stroke risk and bleed risk on anticoagulation

C	Congestive Heart Failure	1

H	Hypertension	1

A2	Age >75	2

D	Diabetes Mellitus	1

S2	Stroke,
CHA2DS2VASc vs HAS-BLED scores ... on anticoagulation ... S Stroke 1 B Bleeding ... #AFib #Diagnosis ... #Hematology
Causes of Bleeding / Bruising - Differential Diagnosis Algorithm
Thrombocytopenia - Quantitative Defect
 • Decreased Production
 •
Causes of Bleeding ... - Differential Diagnosis ... Algorithm Thrombocytopenia ... - Acquired • Anticoagulation ... #Hematology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
factors that could ... event, follow ACC algorithm ... Anticoagulation ... - what is the bleeding ... stratification #diagnosis
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
factor - Stop at ... PE - High Bleeding ... - Not High Bleeding ... #management #hematology ... #anticoagulation
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
• Treatment algorithms ... patients with no CV risk ... factors) - ... Hydroxyurea + anticoagulation ... #hematology